Pith. sign in

REVIEW 3 cited by

DrugLLM: Open Large Language Model for Few-shot Molecule Generation

Not yet reviewed by Pith; the record is open.

This paper has not been read by Pith yet. Machine review is queued; the pith claim, tier, and objections will appear here once it completes.

SPECIMEN: schema-true, not a live event

T0 review · schema-true

One-sentence machine reading of the paper's core claim.

pith:XXXXXXXX · record.json · timestamp

arxiv 2405.06690 v1 pith:OKWLCP2S submitted 2024-05-07 q-bio.BM cs.CLcs.LG

classification q-bio.BMcs.CLcs.LG
keywords drugllmfew-shotmoleculecapacitydruglanguagemoleculesproperties
verification ladder T0 review T1 audit T2 compute T3 formal
0 comments
read the original abstract

Large Language Models (LLMs) have made great strides in areas such as language processing and computer vision. Despite the emergence of diverse techniques to improve few-shot learning capacity, current LLMs fall short in handling the languages in biology and chemistry. For example, they are struggling to capture the relationship between molecule structure and pharmacochemical properties. Consequently, the few-shot learning capacity of small-molecule drug modification remains impeded. In this work, we introduced DrugLLM, a LLM tailored for drug design. During the training process, we employed Group-based Molecular Representation (GMR) to represent molecules, arranging them in sequences that reflect modifications aimed at enhancing specific molecular properties. DrugLLM learns how to modify molecules in drug discovery by predicting the next molecule based on past modifications. Extensive computational experiments demonstrate that DrugLLM can generate new molecules with expected properties based on limited examples, presenting a powerful few-shot molecule generation capacity.

Discussion (0). Sign in to comment.

Forward citations

Cited by 3 Pith papers

Reviewed papers in the Pith corpus that reference this work. Sorted by Pith novelty score. Full citation record

  1. DrugGen 2: A disease-aware language model for enhancing drug discovery

    q-bio.QM 2026-07 conditional novelty 6.0 of 10

    A GPT-2 model fine-tuned with disease MeSH + protein sequence inputs and GRPO rewards produces more unique, valid, drug-like, high-PLAPT-affinity ligands than DrugGPT or DrugGen on five diabetic-nephropathy targets.

  2. DeepRetro: Retrosynthetic Pathway Discovery using Iterative LLM Reasoning

    q-bio.QM 2025-07 conditional novelty 6.0 of 10

    DeepRetro combines LLM-generated retrosynthetic disconnections with template-based search and human feedback, achieving strong benchmark results and proposing new routes for complex natural products.

  3. Domain Specific Benchmarks for Evaluating Multimodal Large Language Models

    cs.LG 2025-06 conditional novelty 3.0 of 10

    A review paper that organizes domain-specific MLLM benchmarks into an eight-discipline taxonomy, with summary tables and performance highlights.

Pith tools